Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
vsak obliž vsebuje 36 mg oksibutinina.
each patch contains 36 mg oxybutynin.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
uporaba oksibutinina med dojenjem ni priporočljiva.
use of oxybutynin is not recommended during breast-feeding.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
en transdermalni obliž vsebuje 36 mg oksibutinina.
each transdermal patch contains 36 mg of oxybutynin.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
en obliž s površino 39 cm2 vsebuje 36 mg oksibutinina.
each patch of 39 cm2 contains 36 mg of oxybutynin.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
prostobazna oblika oksibutinina je farmakološko ekvivalentna oksibutininijevemu kloridu.
the free base form of oxybutynin is pharmacologically equivalent to oxybutynin hydrochloride.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
en transdermalni obliž sprosti 3,9 mg oksibutinina v 24 urah.
each transdermal patch releases 3.9 mg of oxybutynin per 24 hours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
prosta osnovna oblika oksibutinina je farmakološko ekvivalentna oksibutininijevemu kloridu.
the free base form of oxybutynin is pharmacologically equivalent to oxybutynin hydrochloride.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
majhna količina peroralno uporabljenega oksibutinina se izloča v materino mleko.
a small amount of orally administered oxybutynin is excreted in the mother’s milk.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
površina obliža 39 cm2 sprošča nominalnih 3,9 mg oksibutinina na 24 ur.
the area of the patch is 39 cm2, releasing a nominal 3.9 mg of oxybutynin per 24 hours.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
površina obliža 39 cm2 sproš a nominalnih 3. 9 mg oksibutinina na 24 ur.
the area of the patch is 39 cm2 releasing a nominal 3.9 mg of oxybutynin per 24 hours.
Last Update: 2012-04-11
Usage Frequency: 6
Quality:
koncentracije oksibutinina v plazmi se začnejo manjšati 24 ur po uporabi zdravila kentera.
plasma concentrations of oxybutynin begin to decline 24 hours after kentera application.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
koncentracija oksibutinina v plazmi pade v 1 do 2 urah po odstranitvi transdermalnega sistema / sistemov.
plasma concentration of oxybutynin declines within 1 to 2 hours after removal of transdermal system(s).
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
zdravilo kentera je pripravljeno za uporabo enkrat dnevno in lahko vzdržuje terapevtske ravni oksibutinina v krvi.
kentera is formulated for daily application and is capable of maintaining therapeutic blood levels of oxybutynin.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Če imate težave z nepopolnim praznjenjem mehurja med uriniranjem, lahko uporaba oksibutinina težavo še poveča.
if you experience incomplete bladder emptying during urination, the use of oxybutynin may increase this problem.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
transdermalna aplikacija oksibutinina se presnavlja v zgornjem gastrointestinalnem traktu in jetrih ter zmanjšuje nastajanje metabolita n-dezetil.
transdermal administration of oxybutynin bypasses the first-pass gastrointestinal and hepatic metabolism, reducing the formation of the n-desethyl metabolite.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
ena vrečica z 1 gramom gela vsebuje 90,7 mg oksibutinina, kar predstavlja nominalno dovajanje približno 4 mg/dan.
each sachet of 1 gram of gel contains 90.7 mg of oxybutynin resulting in a nominal delivery of approximately 4 mg/day.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
en odmerjen odmerek z 1 gramom gela vsebuje 90,7 mg oksibutinina, kar predstavlja nominalno dovajanje približno 4 mg/dan.
each metered dose of 1 gram of gel contains 90.7 mg of oxybutynin resulting in a nominal delivery of approximately 4 mg/day.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
koncentracija oksibutinina v obližu kentera je zadostna za vzdrževanje stalnega prenosa učinkovine med 3- do 4-dnevnimi intervali uporabe.
kentera has a concentration of oxybutynin sufficient to maintain continuous transport over the 3 to 4 day dosing interval.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
absorpcija koncentracija oksibutinina v obližu kentera je zadostna za vzdrževanje stalnega prenosa u inkovine med 3 - do 4- dnevnimi intervali uporabe.
absorption kentera has a concentration of oxybutynin sufficient to maintain continuous transport over the 3 to 4 day dosing interval.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
oksibutinin lahko upočasni prebavila in tako vpliva na adsorpcijo drugih peroralnih zdravil, vpliva na zdravljenje izločanja blata, sočasna uporaba tega zdravila in drugih zdravil pa lahko poveča učinek oksibutinina.
oxybutynin may slow the digestive tract and thereby influence the adsorption of other oral medicines, interfere with bowel movement therapies, and the use of this medicine together with other medicines may increase the effect of oxybutynin.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: